Public Sector Pension Investment Board Eagle Pharmaceuticals, Inc. Transaction History

Public Sector Pension Investment Board

$18.3 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$25.06 - $34.09 $15,787 - $21,476	-630 Reduced 3.33%	18,314 $519,000
Q4 2022 Feb 14, 2023	SELL	$24.98 - $39.77 $13,414 - $21,356	-537 Reduced 2.76%	18,944 $553,000
Q3 2022 Nov 14, 2022	SELL	$26.42 - $47.12 $31,862 - $56,826	-1,206 Reduced 5.83%	19,481 $515,000
Q2 2022 Aug 12, 2022	SELL	$41.26 - $51.35 $24,095 - $29,988	-584 Reduced 2.75%	20,687 $919,000
Q1 2022 May 13, 2022	SELL	$44.58 - $52.6 $83,810 - $98,888	-1,880 Reduced 8.12%	21,271 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$45.82 - $56.9 $6,414 - $7,966	-140 Reduced 0.6%	23,151 $1.18 Million
Q3 2021 Nov 12, 2021	SELL	$43.79 - $55.78 $115,255 - $146,812	-2,632 Reduced 10.15%	23,291 $1.3 Million
Q2 2021 Aug 13, 2021	SELL	$36.86 - $44.5 $131,774 - $159,087	-3,575 Reduced 12.12%	25,923 $1.11 Million
Q1 2021 May 14, 2021	BUY	$40.32 - $50.97 $154,707 - $195,571	3,837 Added 14.95%	29,498 $1.23 Million
Q4 2020 Feb 12, 2021	SELL	$41.72 - $51.34 $47,978 - $59,041	-1,150 Reduced 4.29%	25,661 $1.2 Million
Q3 2020 Nov 13, 2020	BUY	$37.02 - $51.28 $154,743 - $214,350	4,180 Added 18.47%	26,811 $1.14 Million
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $162,960 - $192,930	-3,000 Reduced 11.7%	22,631 $1.36 Million
Q3 2019 Nov 14, 2019	BUY	$53.25 - $59.98 $156,555 - $176,341	2,940 Added 12.96%	25,631 $1.45 Million
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $601,269 - $754,005	12,900 Added 131.75%	22,691 $1.26 Million
Q4 2018 Feb 14, 2019	BUY	$36.72 - $67.73 $77,112 - $142,233	2,100 Added 27.3%	9,791 $394,000
Q3 2018 Nov 14, 2018	BUY	$66.65 - $83.86 $171,490 - $215,771	2,573 Added 50.27%	7,691 $533,000
Q3 2017 Nov 14, 2017	BUY	$46.62 - $60.36 $238,601 - $308,922	5,118	5,118 $0

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.

Account